Table 3.
Multivariate Cox regression analysis of prognostic factors for progression-free survival and overall survival.
| Clinical characteristics | Progression-free survival | Overall survival | ||
|---|---|---|---|---|
| Hazard ratio(95% CI) | p | Hazard ratio(95% CI) | p | |
| Gender | 2.581(0.998-6.678) | 0.051 | 1.119(0.426-2.941) | 0.820 |
| Age | 0.549(0.249-1.209) | 0.137 | 0.777(0.353-1.709) | 0.530 |
| Liver metastasis | 0.398(0.157-1.009) | 0.052 | 0.372(0.138-1.003) | 0.051 |
| Lung metastasis | 0.666(0.141-3.148) | 0.608 | 0.471(0.097-2.296) | 0.352 |
| Ascites and/or pleural effusion | 0.416(0.161-1.076) | 0.070 | 0.400(0.133-1.207) | 0.104 |
| Severe loss of VFA and/or SMA | 0.325(0.134-0.788) | 0.013 | 0.352(0.137-0.903) | 0.030 |